GLS and cancer: Of particular interest is the limited cytotoxic activity observed on non‐malignant cells of GLS1 inhibitors as a single agent or in pairwise combinations with the other drugs tested in this study, which predicts for these combinations a significant therapeutic margin in cancer management.